HYGEIA HEALTH (06078) plans to repurchase company shares.

HYGEIA HEALTH (06078) issued an announcement regarding the general authorization granted by the shareholders at the company's annual general meeting held on June 27, 2025, for the repurchase of the company's shares. Under the repurchase authorization, the company is allowed to repurchase up to 61.8499 million shares, representing 10% of the total number of shares issued as of the date of the annual general meeting (excluding treasury shares). The company believes that the current trading price of the shares does not reflect their intrinsic value or the actual business prospects of the company. Therefore, the board of directors has decided to utilize the repurchase authorization to repurchase shares on the open market at a total price of not less than RMB 300 million from time to time. The company believes that the proposed share repurchase will demonstrate the company's confidence in its own business development prospects, and the existing financial resources of the company will be sufficient to support the implementation of the proposed share repurchase while maintaining a solid financial position. The company will continue to optimize shareholder returns based on market conditions, making more efficient and shareholder value-enhancing capital allocation arrangements in repurchases, dividends, and merger and acquisition expansions.